Which has the lower trailing P/E, CME or MRSH?

MRSH has the lower trailing P/E: CME trades at 23.11 and MRSH at 21.61. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CME or MRSH?

Over the past five years, MRSH grew revenue faster — CME at a 7.99% CAGR versus MRSH at 8.62%.

Does CME or MRSH pay a bigger dividend?

CME yields 1.38% and MRSH yields 2.09% based on trailing dividends and the latest price.

Is CME or MRSH more profitable?

CME runs the higher net margin — CME at 63.08% versus MRSH at 14.24%.

How have CME and MRSH total returns compared?

Over the past 10 years, CME delivered 14.06% and MRSH delivered 12.23% annualized total return. Past performance doesn't predict future results.

CME Group Inc. (CME) vs Marsh & McLennan Companies, Inc. (MRSH)

A side-by-side comparison of CME Group Inc. and Marsh & McLennan Companies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

CME

CME Group Inc.

$97.97B

$272.46Financial ServicesDelayed quote: Sep 16, 2026, 4:00 PM EDT

MRSH

Marsh & McLennan Companies, Inc.

$84.34B

$176.74Financial ServicesDelayed quote: Sep 16, 2026, 3:59 PM EDT

Total return — CME vs MRSH

growth of $100 · dividends reinvested · last 10y

CME +260.5% (+13.7%/yr)MRSH +217.6% (+12.3%/yr)CME compounded faster over this window

CME MRSH

CME vs MRSH: by the numbers

•CME is the larger company ($97.97B vs $84.34B market cap).
•MRSH trades at the lower trailing earnings multiple (21.61 vs 23.11 P/E), one valuation lens rather than an overall verdict.
•CME converts more revenue to profit (63.08% vs 14.24% net margin).
•MRSH grew revenue faster over the past five years (8.62% vs 7.99% CAGR).
•MRSH pays the higher dividend yield (2.09% vs 1.38%).

Metrics side by side

Valuation

Metric	CME	MRSH
P/E ratio	23.11	21.61
Forward P/E	22.24	16.92
P/S ratio	14.47	3.02
P/B ratio	3.69	5.56

Profitability

Metric	CME	MRSH
Gross margin	81.89%	42.38%
Operating margin	65.10%	21.62%
Net margin	63.08%	14.24%
ROE	16.11%	26.21%

Dividends

Metric	CME	MRSH
Dividend yield	1.38%	2.09%
Payout ratio	32.23%	45.11%

Growth (annualized)

Metric	CME	MRSH
Revenue CAGR (5Y)	7.99%	8.62%
EPS CAGR (5Y)	13.72%	16.34%
Total return CAGR (5Y)	11.89%	3.56%

Frequently asked

Which has the lower trailing P/E, CME or MRSH?: MRSH has the lower trailing P/E: CME trades at 23.11 and MRSH at 21.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CME or MRSH?: Over the past five years, MRSH grew revenue faster — CME at a 7.99% CAGR versus MRSH at 8.62%.
Does CME or MRSH pay a bigger dividend?: CME yields 1.38% and MRSH yields 2.09% based on trailing dividends and the latest price.
Is CME or MRSH more profitable?: CME runs the higher net margin — CME at 63.08% versus MRSH at 14.24%.
How have CME and MRSH total returns compared?: Over the past 10 years, CME delivered 14.06% and MRSH delivered 12.23% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CME analysis Full MRSH analysis Interactive comparison tool

Dig into the metrics

CME P/E ratio Marsh & McLennan Companies P/E ratio CME dividend yield Marsh & McLennan Companies dividend yield CME ROE Marsh & McLennan Companies ROE CME operating margin Marsh & McLennan Companies operating margin CME revenue growth Marsh & McLennan Companies revenue growth

CME & Marsh & McLennan Companies appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.